This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by NEWMAN, W. P. Articles by BRODOWS, R. G. Search for Related Content PubMed PubMed Citation Articles by NEWMAN, W. P. Articles by BRODOWS, R. G.

Aspirin Causes Tissue Insensitivity to Insulin In Normal Man^*

Department of Medicine, The Genesee Hospital and The University of Rochester School of Medicine and Dentistry Rochester, New York 14607

Address requests for reprints to: Dr. Robert G. Brodows, Department of Medicine, The Genesee Hospital and The University of Rochester School of Medicine and Dentistry, 224 Alexander Street, Rochester, New York 14607.

The effect of aspirin on glucose and insulin metabolism was examined with the hyperglycemic clamp technique in 8 normal volunteers. When the plasma glucose concentration was acutely raised and maintained at 125 mg/dl above the basal level after treatment with aspirin (3 g daily for 3 days), acute (0–10 min) and sustained (20–120 min) insulin release were 70% and 45% greater than before treatment. Despite the increased plasma insulin level, the glucose infusion rate remained unchanged (8 ± 0.9 to 9.1 ± 1.2 mg/kgmin). Consequently, the ratio of the glucose infusion rate to the plasma insulin level, an index of tissue sensitivity to endogenous insulin, decreased by 30%, indicative of impaired insulin action. Aspirin did not alter fasting levels of FFA. When ibuprofen, another prostaglandin synthesis inhibitor, was given to 10 normal volunteers, only an effect on acute insulin release could be demonstrated. These results demonstrate that aspirin not only enhances β-cell sensitivity to glucose, but also impairs glucose metabolism in insulin-sensitive tissues. It is not clear whether these effects are related to aspirin’s ability to inhibit prostaglandin synthesis.

^* This work was supported in part by the Carroll C. Colgan Fund.

Received April 13, 1983.

This article has been cited by other articles:

				C. Xiao, A. Giacca, and G. F. Lewis The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and {beta}-cell dysfunction in overweight and obese nondiabetic men Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1205 - E1211. [Abstract] [Full Text] [PDF]

				A. D. Pradhan, N. R. Cook, J. E. Manson, P. M. Ridker, and J. E. Buring A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women Diabetes Care, January 1, 2009; 32(1): 3 - 8. [Abstract] [Full Text] [PDF]

				J.-M. Fernandez-Real, A. Lopez-Bermejo, A.-B. Ropero, S. Piquer, A. Nadal, J. Bassols, R. Casamitjana, R. Gomis, E. Arnaiz, I. Perez, et al. Salicylates Increase Insulin Secretion in Healthy Obese Subjects J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2523 - 2530. [Abstract] [Full Text] [PDF]

				L. Zu, H. Jiang, J. He, C. Xu, S. Pu, M. Liu, and G. Xu Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-{alpha} in Primary Rat Adipocytes Mol. Pharmacol., January 1, 2008; 73(1): 215 - 223. [Abstract] [Full Text] [PDF]

				N. Asfandiyarova, N. Kolcheva, I. Ryazantsev, and V. Ryazantsev Risk factors for stroke in type 2 diabetes mellitus Diabetes and Vascular Disease Research, May 1, 2006; 3(1): 57 - 60. [Abstract] [PDF]

				M. Mohlig, M. Freudenberg, T. Bobbert, M. Ristow, H. Rochlitz, M. O. Weickert, A. F. H. Pfeiffer, and J. Spranger Acetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 964 - 967. [Abstract] [Full Text] [PDF]

				W. H. Hartl and R. R. Wolfe Review: The Phospholipid/Arachidonic Acid Second Messenger System: Its Possible Role in Physiology and Pathophysiology of Metabolism JPEN J Parenter Enteral Nutr, July 1, 1990; 14(4): 416 - 427. [Abstract] [PDF]